nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Arthralgia—Prednisone—prostate cancer	0.000209	0.000209	CcSEcCtD
Gadoversetamide—Myalgia—Prednisone—prostate cancer	0.000209	0.000209	CcSEcCtD
Gadoversetamide—Paraesthesia—Docetaxel—prostate cancer	0.000209	0.000209	CcSEcCtD
Gadoversetamide—Erythema multiforme—Epirubicin—prostate cancer	0.000209	0.000209	CcSEcCtD
Gadoversetamide—Anxiety—Prednisone—prostate cancer	0.000209	0.000209	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000208	0.000208	CcSEcCtD
Gadoversetamide—Dyspnoea—Docetaxel—prostate cancer	0.000207	0.000207	CcSEcCtD
Gadoversetamide—Somnolence—Docetaxel—prostate cancer	0.000207	0.000207	CcSEcCtD
Gadoversetamide—Discomfort—Prednisone—prostate cancer	0.000207	0.000207	CcSEcCtD
Gadoversetamide—Eye disorder—Epirubicin—prostate cancer	0.000206	0.000206	CcSEcCtD
Gadoversetamide—Hypersensitivity—Etoposide—prostate cancer	0.000206	0.000206	CcSEcCtD
Gadoversetamide—Tinnitus—Epirubicin—prostate cancer	0.000206	0.000206	CcSEcCtD
Gadoversetamide—Haemoglobin—Doxorubicin—prostate cancer	0.000205	0.000205	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000205	0.000205	CcSEcCtD
Gadoversetamide—Flushing—Epirubicin—prostate cancer	0.000205	0.000205	CcSEcCtD
Gadoversetamide—Cardiac disorder—Epirubicin—prostate cancer	0.000205	0.000205	CcSEcCtD
Gadoversetamide—Rhinitis—Doxorubicin—prostate cancer	0.000205	0.000205	CcSEcCtD
Gadoversetamide—Dyspepsia—Docetaxel—prostate cancer	0.000205	0.000205	CcSEcCtD
Gadoversetamide—Haemorrhage—Doxorubicin—prostate cancer	0.000204	0.000204	CcSEcCtD
Gadoversetamide—Insomnia—Capecitabine—prostate cancer	0.000204	0.000204	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Doxorubicin—prostate cancer	0.000203	0.000203	CcSEcCtD
Gadoversetamide—Pharyngitis—Doxorubicin—prostate cancer	0.000203	0.000203	CcSEcCtD
Gadoversetamide—Paraesthesia—Capecitabine—prostate cancer	0.000202	0.000202	CcSEcCtD
Gadoversetamide—Decreased appetite—Docetaxel—prostate cancer	0.000202	0.000202	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Doxorubicin—prostate cancer	0.000202	0.000202	CcSEcCtD
Gadoversetamide—Oedema peripheral—Doxorubicin—prostate cancer	0.000201	0.000201	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000201	0.000201	CcSEcCtD
Gadoversetamide—Asthenia—Etoposide—prostate cancer	0.000201	0.000201	CcSEcCtD
Gadoversetamide—Dyspnoea—Capecitabine—prostate cancer	0.000201	0.000201	CcSEcCtD
Gadoversetamide—Oedema—Prednisone—prostate cancer	0.000201	0.000201	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Prednisone—prostate cancer	0.000201	0.000201	CcSEcCtD
Gadoversetamide—Fatigue—Docetaxel—prostate cancer	0.000201	0.000201	CcSEcCtD
Gadoversetamide—Angiopathy—Epirubicin—prostate cancer	0.0002	0.0002	CcSEcCtD
Gadoversetamide—Urethral disorder—Doxorubicin—prostate cancer	0.0002	0.0002	CcSEcCtD
Gadoversetamide—Nausea—Mitoxantrone—prostate cancer	0.0002	0.0002	CcSEcCtD
Gadoversetamide—Immune system disorder—Epirubicin—prostate cancer	0.0002	0.0002	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Epirubicin—prostate cancer	0.000199	0.000199	CcSEcCtD
Gadoversetamide—Pain—Docetaxel—prostate cancer	0.000199	0.000199	CcSEcCtD
Gadoversetamide—Constipation—Docetaxel—prostate cancer	0.000199	0.000199	CcSEcCtD
Gadoversetamide—Dyspepsia—Capecitabine—prostate cancer	0.000198	0.000198	CcSEcCtD
Gadoversetamide—Chills—Epirubicin—prostate cancer	0.000198	0.000198	CcSEcCtD
Gadoversetamide—Pruritus—Etoposide—prostate cancer	0.000198	0.000198	CcSEcCtD
Gadoversetamide—Shock—Prednisone—prostate cancer	0.000197	0.000197	CcSEcCtD
Gadoversetamide—Arrhythmia—Epirubicin—prostate cancer	0.000197	0.000197	CcSEcCtD
Gadoversetamide—Nervous system disorder—Prednisone—prostate cancer	0.000197	0.000197	CcSEcCtD
Gadoversetamide—Tachycardia—Prednisone—prostate cancer	0.000196	0.000196	CcSEcCtD
Gadoversetamide—Decreased appetite—Capecitabine—prostate cancer	0.000196	0.000196	CcSEcCtD
Gadoversetamide—Skin disorder—Prednisone—prostate cancer	0.000195	0.000195	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000195	0.000195	CcSEcCtD
Gadoversetamide—Fatigue—Capecitabine—prostate cancer	0.000194	0.000194	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Prednisone—prostate cancer	0.000194	0.000194	CcSEcCtD
Gadoversetamide—Mental disorder—Epirubicin—prostate cancer	0.000194	0.000194	CcSEcCtD
Gadoversetamide—Erythema multiforme—Doxorubicin—prostate cancer	0.000193	0.000193	CcSEcCtD
Gadoversetamide—Pain—Capecitabine—prostate cancer	0.000193	0.000193	CcSEcCtD
Gadoversetamide—Constipation—Capecitabine—prostate cancer	0.000193	0.000193	CcSEcCtD
Gadoversetamide—Erythema—Epirubicin—prostate cancer	0.000192	0.000192	CcSEcCtD
Gadoversetamide—Malnutrition—Epirubicin—prostate cancer	0.000192	0.000192	CcSEcCtD
Gadoversetamide—Feeling abnormal—Docetaxel—prostate cancer	0.000192	0.000192	CcSEcCtD
Gadoversetamide—Diarrhoea—Etoposide—prostate cancer	0.000192	0.000192	CcSEcCtD
Gadoversetamide—Anorexia—Prednisone—prostate cancer	0.000191	0.000191	CcSEcCtD
Gadoversetamide—Eye disorder—Doxorubicin—prostate cancer	0.000191	0.000191	CcSEcCtD
Gadoversetamide—Tinnitus—Doxorubicin—prostate cancer	0.000191	0.000191	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Docetaxel—prostate cancer	0.00019	0.00019	CcSEcCtD
Gadoversetamide—Cardiac disorder—Doxorubicin—prostate cancer	0.00019	0.00019	CcSEcCtD
Gadoversetamide—Flushing—Doxorubicin—prostate cancer	0.00019	0.00019	CcSEcCtD
Gadoversetamide—Flatulence—Epirubicin—prostate cancer	0.00019	0.00019	CcSEcCtD
Gadoversetamide—Tension—Epirubicin—prostate cancer	0.000189	0.000189	CcSEcCtD
Gadoversetamide—Dysgeusia—Epirubicin—prostate cancer	0.000188	0.000188	CcSEcCtD
Gadoversetamide—Nervousness—Epirubicin—prostate cancer	0.000187	0.000187	CcSEcCtD
Gadoversetamide—Back pain—Epirubicin—prostate cancer	0.000186	0.000186	CcSEcCtD
Gadoversetamide—Feeling abnormal—Capecitabine—prostate cancer	0.000186	0.000186	CcSEcCtD
Gadoversetamide—Angiopathy—Doxorubicin—prostate cancer	0.000185	0.000185	CcSEcCtD
Gadoversetamide—Dizziness—Etoposide—prostate cancer	0.000185	0.000185	CcSEcCtD
Gadoversetamide—Muscle spasms—Epirubicin—prostate cancer	0.000185	0.000185	CcSEcCtD
Gadoversetamide—Immune system disorder—Doxorubicin—prostate cancer	0.000185	0.000185	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Capecitabine—prostate cancer	0.000184	0.000184	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Doxorubicin—prostate cancer	0.000184	0.000184	CcSEcCtD
Gadoversetamide—Abdominal pain—Docetaxel—prostate cancer	0.000184	0.000184	CcSEcCtD
Gadoversetamide—Body temperature increased—Docetaxel—prostate cancer	0.000184	0.000184	CcSEcCtD
Gadoversetamide—Chills—Doxorubicin—prostate cancer	0.000183	0.000183	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000183	0.000183	CcSEcCtD
Gadoversetamide—Arrhythmia—Doxorubicin—prostate cancer	0.000183	0.000183	CcSEcCtD
Gadoversetamide—Insomnia—Prednisone—prostate cancer	0.000182	0.000182	CcSEcCtD
Gadoversetamide—Vision blurred—Epirubicin—prostate cancer	0.000181	0.000181	CcSEcCtD
Gadoversetamide—Paraesthesia—Prednisone—prostate cancer	0.00018	0.00018	CcSEcCtD
Gadoversetamide—Mental disorder—Doxorubicin—prostate cancer	0.000179	0.000179	CcSEcCtD
Gadoversetamide—Urticaria—Capecitabine—prostate cancer	0.000179	0.000179	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Epirubicin—prostate cancer	0.000178	0.000178	CcSEcCtD
Gadoversetamide—Abdominal pain—Capecitabine—prostate cancer	0.000178	0.000178	CcSEcCtD
Gadoversetamide—Body temperature increased—Capecitabine—prostate cancer	0.000178	0.000178	CcSEcCtD
Gadoversetamide—Vomiting—Etoposide—prostate cancer	0.000178	0.000178	CcSEcCtD
Gadoversetamide—Malnutrition—Doxorubicin—prostate cancer	0.000178	0.000178	CcSEcCtD
Gadoversetamide—Erythema—Doxorubicin—prostate cancer	0.000178	0.000178	CcSEcCtD
Gadoversetamide—Agitation—Epirubicin—prostate cancer	0.000177	0.000177	CcSEcCtD
Gadoversetamide—Dyspepsia—Prednisone—prostate cancer	0.000177	0.000177	CcSEcCtD
Gadoversetamide—Rash—Etoposide—prostate cancer	0.000177	0.000177	CcSEcCtD
Gadoversetamide—Dermatitis—Etoposide—prostate cancer	0.000176	0.000176	CcSEcCtD
Gadoversetamide—Headache—Etoposide—prostate cancer	0.000175	0.000175	CcSEcCtD
Gadoversetamide—Flatulence—Doxorubicin—prostate cancer	0.000175	0.000175	CcSEcCtD
Gadoversetamide—Tension—Doxorubicin—prostate cancer	0.000175	0.000175	CcSEcCtD
Gadoversetamide—Decreased appetite—Prednisone—prostate cancer	0.000174	0.000174	CcSEcCtD
Gadoversetamide—Dysgeusia—Doxorubicin—prostate cancer	0.000174	0.000174	CcSEcCtD
Gadoversetamide—Malaise—Epirubicin—prostate cancer	0.000173	0.000173	CcSEcCtD
Gadoversetamide—Fatigue—Prednisone—prostate cancer	0.000173	0.000173	CcSEcCtD
Gadoversetamide—Nervousness—Doxorubicin—prostate cancer	0.000173	0.000173	CcSEcCtD
Gadoversetamide—Vertigo—Epirubicin—prostate cancer	0.000173	0.000173	CcSEcCtD
Gadoversetamide—Syncope—Epirubicin—prostate cancer	0.000172	0.000172	CcSEcCtD
Gadoversetamide—Back pain—Doxorubicin—prostate cancer	0.000172	0.000172	CcSEcCtD
Gadoversetamide—Constipation—Prednisone—prostate cancer	0.000172	0.000172	CcSEcCtD
Gadoversetamide—Hypersensitivity—Docetaxel—prostate cancer	0.000171	0.000171	CcSEcCtD
Gadoversetamide—Muscle spasms—Doxorubicin—prostate cancer	0.000171	0.000171	CcSEcCtD
Gadoversetamide—Palpitations—Epirubicin—prostate cancer	0.00017	0.00017	CcSEcCtD
Gadoversetamide—Loss of consciousness—Epirubicin—prostate cancer	0.000169	0.000169	CcSEcCtD
Gadoversetamide—Cough—Epirubicin—prostate cancer	0.000168	0.000168	CcSEcCtD
Gadoversetamide—Vision blurred—Doxorubicin—prostate cancer	0.000168	0.000168	CcSEcCtD
Gadoversetamide—Asthenia—Docetaxel—prostate cancer	0.000167	0.000167	CcSEcCtD
Gadoversetamide—Convulsion—Epirubicin—prostate cancer	0.000167	0.000167	CcSEcCtD
Gadoversetamide—Nausea—Etoposide—prostate cancer	0.000166	0.000166	CcSEcCtD
Gadoversetamide—Hypertension—Epirubicin—prostate cancer	0.000166	0.000166	CcSEcCtD
Gadoversetamide—Hypersensitivity—Capecitabine—prostate cancer	0.000166	0.000166	CcSEcCtD
Gadoversetamide—Feeling abnormal—Prednisone—prostate cancer	0.000165	0.000165	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Doxorubicin—prostate cancer	0.000165	0.000165	CcSEcCtD
Gadoversetamide—Pruritus—Docetaxel—prostate cancer	0.000165	0.000165	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Prednisone—prostate cancer	0.000164	0.000164	CcSEcCtD
Gadoversetamide—Chest pain—Epirubicin—prostate cancer	0.000164	0.000164	CcSEcCtD
Gadoversetamide—Myalgia—Epirubicin—prostate cancer	0.000164	0.000164	CcSEcCtD
Gadoversetamide—Arthralgia—Epirubicin—prostate cancer	0.000164	0.000164	CcSEcCtD
Gadoversetamide—Agitation—Doxorubicin—prostate cancer	0.000164	0.000164	CcSEcCtD
Gadoversetamide—Anxiety—Epirubicin—prostate cancer	0.000163	0.000163	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000163	0.000163	CcSEcCtD
Gadoversetamide—Discomfort—Epirubicin—prostate cancer	0.000162	0.000162	CcSEcCtD
Gadoversetamide—Asthenia—Capecitabine—prostate cancer	0.000162	0.000162	CcSEcCtD
Gadoversetamide—Malaise—Doxorubicin—prostate cancer	0.00016	0.00016	CcSEcCtD
Gadoversetamide—Dry mouth—Epirubicin—prostate cancer	0.00016	0.00016	CcSEcCtD
Gadoversetamide—Vertigo—Doxorubicin—prostate cancer	0.00016	0.00016	CcSEcCtD
Gadoversetamide—Syncope—Doxorubicin—prostate cancer	0.00016	0.00016	CcSEcCtD
Gadoversetamide—Urticaria—Prednisone—prostate cancer	0.000159	0.000159	CcSEcCtD
Gadoversetamide—Pruritus—Capecitabine—prostate cancer	0.000159	0.000159	CcSEcCtD
Gadoversetamide—Diarrhoea—Docetaxel—prostate cancer	0.000159	0.000159	CcSEcCtD
Gadoversetamide—Abdominal pain—Prednisone—prostate cancer	0.000159	0.000159	CcSEcCtD
Gadoversetamide—Body temperature increased—Prednisone—prostate cancer	0.000159	0.000159	CcSEcCtD
Gadoversetamide—Confusional state—Epirubicin—prostate cancer	0.000158	0.000158	CcSEcCtD
Gadoversetamide—Palpitations—Doxorubicin—prostate cancer	0.000157	0.000157	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Epirubicin—prostate cancer	0.000157	0.000157	CcSEcCtD
Gadoversetamide—Oedema—Epirubicin—prostate cancer	0.000157	0.000157	CcSEcCtD
Gadoversetamide—Loss of consciousness—Doxorubicin—prostate cancer	0.000156	0.000156	CcSEcCtD
Gadoversetamide—Cough—Doxorubicin—prostate cancer	0.000155	0.000155	CcSEcCtD
Gadoversetamide—Shock—Epirubicin—prostate cancer	0.000154	0.000154	CcSEcCtD
Gadoversetamide—Convulsion—Doxorubicin—prostate cancer	0.000154	0.000154	CcSEcCtD
Gadoversetamide—Diarrhoea—Capecitabine—prostate cancer	0.000154	0.000154	CcSEcCtD
Gadoversetamide—Nervous system disorder—Epirubicin—prostate cancer	0.000154	0.000154	CcSEcCtD
Gadoversetamide—Dizziness—Docetaxel—prostate cancer	0.000154	0.000154	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Epirubicin—prostate cancer	0.000154	0.000154	CcSEcCtD
Gadoversetamide—Hypertension—Doxorubicin—prostate cancer	0.000154	0.000154	CcSEcCtD
Gadoversetamide—Tachycardia—Epirubicin—prostate cancer	0.000153	0.000153	CcSEcCtD
Gadoversetamide—Skin disorder—Epirubicin—prostate cancer	0.000152	0.000152	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Epirubicin—prostate cancer	0.000152	0.000152	CcSEcCtD
Gadoversetamide—Chest pain—Doxorubicin—prostate cancer	0.000152	0.000152	CcSEcCtD
Gadoversetamide—Myalgia—Doxorubicin—prostate cancer	0.000152	0.000152	CcSEcCtD
Gadoversetamide—Arthralgia—Doxorubicin—prostate cancer	0.000152	0.000152	CcSEcCtD
Gadoversetamide—Anxiety—Doxorubicin—prostate cancer	0.000151	0.000151	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.00015	0.00015	CcSEcCtD
Gadoversetamide—Discomfort—Doxorubicin—prostate cancer	0.00015	0.00015	CcSEcCtD
Gadoversetamide—Anorexia—Epirubicin—prostate cancer	0.00015	0.00015	CcSEcCtD
Gadoversetamide—Dizziness—Capecitabine—prostate cancer	0.000149	0.000149	CcSEcCtD
Gadoversetamide—Dry mouth—Doxorubicin—prostate cancer	0.000148	0.000148	CcSEcCtD
Gadoversetamide—Vomiting—Docetaxel—prostate cancer	0.000148	0.000148	CcSEcCtD
Gadoversetamide—Hypersensitivity—Prednisone—prostate cancer	0.000148	0.000148	CcSEcCtD
Gadoversetamide—Rash—Docetaxel—prostate cancer	0.000147	0.000147	CcSEcCtD
Gadoversetamide—Hypotension—Epirubicin—prostate cancer	0.000147	0.000147	CcSEcCtD
Gadoversetamide—Dermatitis—Docetaxel—prostate cancer	0.000147	0.000147	CcSEcCtD
Gadoversetamide—Confusional state—Doxorubicin—prostate cancer	0.000146	0.000146	CcSEcCtD
Gadoversetamide—Headache—Docetaxel—prostate cancer	0.000146	0.000146	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Doxorubicin—prostate cancer	0.000145	0.000145	CcSEcCtD
Gadoversetamide—Oedema—Doxorubicin—prostate cancer	0.000145	0.000145	CcSEcCtD
Gadoversetamide—Asthenia—Prednisone—prostate cancer	0.000144	0.000144	CcSEcCtD
Gadoversetamide—Vomiting—Capecitabine—prostate cancer	0.000143	0.000143	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000143	0.000143	CcSEcCtD
Gadoversetamide—Shock—Doxorubicin—prostate cancer	0.000143	0.000143	CcSEcCtD
Gadoversetamide—Nervous system disorder—Doxorubicin—prostate cancer	0.000142	0.000142	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Doxorubicin—prostate cancer	0.000142	0.000142	CcSEcCtD
Gadoversetamide—Rash—Capecitabine—prostate cancer	0.000142	0.000142	CcSEcCtD
Gadoversetamide—Pruritus—Prednisone—prostate cancer	0.000142	0.000142	CcSEcCtD
Gadoversetamide—Insomnia—Epirubicin—prostate cancer	0.000142	0.000142	CcSEcCtD
Gadoversetamide—Dermatitis—Capecitabine—prostate cancer	0.000142	0.000142	CcSEcCtD
Gadoversetamide—Tachycardia—Doxorubicin—prostate cancer	0.000142	0.000142	CcSEcCtD
Gadoversetamide—Headache—Capecitabine—prostate cancer	0.000141	0.000141	CcSEcCtD
Gadoversetamide—Skin disorder—Doxorubicin—prostate cancer	0.000141	0.000141	CcSEcCtD
Gadoversetamide—Paraesthesia—Epirubicin—prostate cancer	0.000141	0.000141	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Doxorubicin—prostate cancer	0.00014	0.00014	CcSEcCtD
Gadoversetamide—Dyspnoea—Epirubicin—prostate cancer	0.00014	0.00014	CcSEcCtD
Gadoversetamide—Somnolence—Epirubicin—prostate cancer	0.00014	0.00014	CcSEcCtD
Gadoversetamide—Anorexia—Doxorubicin—prostate cancer	0.000138	0.000138	CcSEcCtD
Gadoversetamide—Nausea—Docetaxel—prostate cancer	0.000138	0.000138	CcSEcCtD
Gadoversetamide—Dyspepsia—Epirubicin—prostate cancer	0.000138	0.000138	CcSEcCtD
Gadoversetamide—Diarrhoea—Prednisone—prostate cancer	0.000137	0.000137	CcSEcCtD
Gadoversetamide—Decreased appetite—Epirubicin—prostate cancer	0.000136	0.000136	CcSEcCtD
Gadoversetamide—Hypotension—Doxorubicin—prostate cancer	0.000136	0.000136	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000136	0.000136	CcSEcCtD
Gadoversetamide—Fatigue—Epirubicin—prostate cancer	0.000135	0.000135	CcSEcCtD
Gadoversetamide—Constipation—Epirubicin—prostate cancer	0.000134	0.000134	CcSEcCtD
Gadoversetamide—Pain—Epirubicin—prostate cancer	0.000134	0.000134	CcSEcCtD
Gadoversetamide—Nausea—Capecitabine—prostate cancer	0.000134	0.000134	CcSEcCtD
Gadoversetamide—Dizziness—Prednisone—prostate cancer	0.000133	0.000133	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000132	0.000132	CcSEcCtD
Gadoversetamide—Insomnia—Doxorubicin—prostate cancer	0.000131	0.000131	CcSEcCtD
Gadoversetamide—Paraesthesia—Doxorubicin—prostate cancer	0.00013	0.00013	CcSEcCtD
Gadoversetamide—Dyspnoea—Doxorubicin—prostate cancer	0.000129	0.000129	CcSEcCtD
Gadoversetamide—Feeling abnormal—Epirubicin—prostate cancer	0.000129	0.000129	CcSEcCtD
Gadoversetamide—Somnolence—Doxorubicin—prostate cancer	0.000129	0.000129	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Epirubicin—prostate cancer	0.000128	0.000128	CcSEcCtD
Gadoversetamide—Dyspepsia—Doxorubicin—prostate cancer	0.000128	0.000128	CcSEcCtD
Gadoversetamide—Vomiting—Prednisone—prostate cancer	0.000128	0.000128	CcSEcCtD
Gadoversetamide—Rash—Prednisone—prostate cancer	0.000127	0.000127	CcSEcCtD
Gadoversetamide—Dermatitis—Prednisone—prostate cancer	0.000126	0.000126	CcSEcCtD
Gadoversetamide—Decreased appetite—Doxorubicin—prostate cancer	0.000126	0.000126	CcSEcCtD
Gadoversetamide—Headache—Prednisone—prostate cancer	0.000126	0.000126	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000125	0.000125	CcSEcCtD
Gadoversetamide—Fatigue—Doxorubicin—prostate cancer	0.000125	0.000125	CcSEcCtD
Gadoversetamide—Urticaria—Epirubicin—prostate cancer	0.000125	0.000125	CcSEcCtD
Gadoversetamide—Constipation—Doxorubicin—prostate cancer	0.000124	0.000124	CcSEcCtD
Gadoversetamide—Pain—Doxorubicin—prostate cancer	0.000124	0.000124	CcSEcCtD
Gadoversetamide—Abdominal pain—Epirubicin—prostate cancer	0.000124	0.000124	CcSEcCtD
Gadoversetamide—Body temperature increased—Epirubicin—prostate cancer	0.000124	0.000124	CcSEcCtD
Gadoversetamide—Feeling abnormal—Doxorubicin—prostate cancer	0.00012	0.00012	CcSEcCtD
Gadoversetamide—Nausea—Prednisone—prostate cancer	0.000119	0.000119	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000119	0.000119	CcSEcCtD
Gadoversetamide—Hypersensitivity—Epirubicin—prostate cancer	0.000116	0.000116	CcSEcCtD
Gadoversetamide—Urticaria—Doxorubicin—prostate cancer	0.000115	0.000115	CcSEcCtD
Gadoversetamide—Body temperature increased—Doxorubicin—prostate cancer	0.000115	0.000115	CcSEcCtD
Gadoversetamide—Abdominal pain—Doxorubicin—prostate cancer	0.000115	0.000115	CcSEcCtD
Gadoversetamide—Asthenia—Epirubicin—prostate cancer	0.000113	0.000113	CcSEcCtD
Gadoversetamide—Pruritus—Epirubicin—prostate cancer	0.000111	0.000111	CcSEcCtD
Gadoversetamide—Diarrhoea—Epirubicin—prostate cancer	0.000107	0.000107	CcSEcCtD
Gadoversetamide—Hypersensitivity—Doxorubicin—prostate cancer	0.000107	0.000107	CcSEcCtD
Gadoversetamide—Asthenia—Doxorubicin—prostate cancer	0.000104	0.000104	CcSEcCtD
Gadoversetamide—Dizziness—Epirubicin—prostate cancer	0.000104	0.000104	CcSEcCtD
Gadoversetamide—Pruritus—Doxorubicin—prostate cancer	0.000103	0.000103	CcSEcCtD
Gadoversetamide—Vomiting—Epirubicin—prostate cancer	9.98e-05	9.98e-05	CcSEcCtD
Gadoversetamide—Diarrhoea—Doxorubicin—prostate cancer	9.94e-05	9.94e-05	CcSEcCtD
Gadoversetamide—Rash—Epirubicin—prostate cancer	9.9e-05	9.9e-05	CcSEcCtD
Gadoversetamide—Dermatitis—Epirubicin—prostate cancer	9.89e-05	9.89e-05	CcSEcCtD
Gadoversetamide—Headache—Epirubicin—prostate cancer	9.83e-05	9.83e-05	CcSEcCtD
Gadoversetamide—Dizziness—Doxorubicin—prostate cancer	9.6e-05	9.6e-05	CcSEcCtD
Gadoversetamide—Nausea—Epirubicin—prostate cancer	9.32e-05	9.32e-05	CcSEcCtD
Gadoversetamide—Vomiting—Doxorubicin—prostate cancer	9.24e-05	9.24e-05	CcSEcCtD
Gadoversetamide—Rash—Doxorubicin—prostate cancer	9.16e-05	9.16e-05	CcSEcCtD
Gadoversetamide—Dermatitis—Doxorubicin—prostate cancer	9.15e-05	9.15e-05	CcSEcCtD
Gadoversetamide—Headache—Doxorubicin—prostate cancer	9.1e-05	9.1e-05	CcSEcCtD
Gadoversetamide—Nausea—Doxorubicin—prostate cancer	8.63e-05	8.63e-05	CcSEcCtD
